Table 5.
Medication changes with normalization of LD in SLE. p values reflect two-tailed χ2 test. p values <0.05 are in italics.
| Patient count | LD | Normalized | p |
|---|---|---|---|
| Hydroxychloroquine (+) | 37 | 32 | 0.90 |
| Hydroxychloroquine (−) | 53 | 44 | |
| Mycophenolic mofetil (+) | 14 | 12 | 0.97 |
| Mycophenolic mofetil (−) | 76 | 64 | |
| Mycophenolic acid (+) | 3 | 2 | 0.79 |
| Mycophenolic acid (−) | 87 | 74 | |
| Azathioprine (+) | 7 | 7 | 0.74 |
| Azathioprine (−) | 83 | 69 | |
| Prednisone (+) | 41 | 47 | 0.043 |
| Prednisone (−) | 49 | 29 | |
| Methotrexate (+) | 5 | 3 | 0.63 |
| Methotrexate (−) | 85 | 73 | |
| Cyclophosphamide (+) | 2 | 3 | 0.52 |
| Cyclophosphamide (−) | 88 | 73 | |
| Cyclosporine (+) | 4 | 6 | 0.75 |
| Cyclosporine (−) | 85 | 83 | |
| Rapamycin (+) | 0 | 2 | 0.155 |
| Rapamycin (−) | 90 | 88 | |
| N-acetylcysteine (+) | 0 | 1 | 1.00 |
| N-acetylcysteine (−) | 90 | 89 | |
| Rituximab (+) | 0 | 0 | NA |
| Rituximab (−) | 90 | 76 | |
| Anti-TNF (+) | 1 | 0 | 0.36 |
| Anti-TNF (−) | 89 | 76 | |
| NSAIDs (+) | 23 | 12 | 0.12 |
| NSAIDs (−) | 67 | 64 |